These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3354339)

  • 41. Measurements of morning and evening airflow grossly underestimate the circadian variability of FEV1 and peak expiratory flow rate in asthma.
    D'Alonzo GE; Steinijans VW; Keller A
    Am J Respir Crit Care Med; 1995 Sep; 152(3):1097-9. PubMed ID: 7663789
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the suitability of weekly peak expiratory flow rate measurements in monitoring annual decline in lung function among patients with asthma and chronic bronchitis.
    Tirimanna PR; Den Otter JJ; Van Schayck CP; Van Herwaarden CL; Folgering H; Van Weel C
    Br J Gen Pract; 1996 Jan; 46(402):15-8. PubMed ID: 8745846
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of weight loss on peak flow variability, airways obstruction, and lung volumes in obese patients with asthma.
    Hakala K; Stenius-Aarniala B; Sovijärvi A
    Chest; 2000 Nov; 118(5):1315-21. PubMed ID: 11083680
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Persisting airway obstruction in asymptomatic children with asthma with normal peak expiratory flow rates.
    Ferguson AC
    J Allergy Clin Immunol; 1988 Jul; 82(1):19-22. PubMed ID: 3392366
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors related to the nocturnal worsening of asthma.
    Martin RJ; Cicutto LC; Ballard RD
    Am Rev Respir Dis; 1990 Jan; 141(1):33-8. PubMed ID: 2404440
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adequacy of control of asthma in a general practice. Is maximum peak expiratory flow rate a valid index of asthma severity?
    Morris NV; Abramson MJ; Strasser RP
    Med J Aust; 1994 Jan; 160(2):68-71. PubMed ID: 8309371
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Two first-line therapies in the treatment of mild asthma: use of peak flow variability as a predictor of effectiveness.
    Nathan RA; Minkwitz MC; Bonuccelli CM
    Ann Allergy Asthma Immunol; 1999 May; 82(5):497-503. PubMed ID: 10353583
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circadian variation in number and affinity of beta 2-adrenoceptors in lymphocytes of asthmatic patients.
    Titinchi S; Al Shamma M; Patel KR; Kerr JW; Clark B
    Clin Sci (Lond); 1984 Mar; 66(3):323-8. PubMed ID: 6319072
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Once daily nebulized beclomethasone is effective in maintaining pulmonary function and improving symptoms in asthmatic children.
    La Grutta S; Nicolini G; Capristo C; Bellodi SC; Rossi GA
    Monaldi Arch Chest Dis; 2007 Mar; 67(1):30-8. PubMed ID: 17564282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Time course of change in oxygen saturation and peak expiratory flow in children admitted to hospital with acute asthma.
    Mihatsch W; Geelhoed GC; Landau LI; LeSouëf PN
    Thorax; 1990 Jun; 45(6):438-41. PubMed ID: 2392787
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.
    Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Taylor DR
    Respir Med; 2000 Aug; 94(8):767-71. PubMed ID: 10955752
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circadian variation in adrenergic responses in asthmatic subjects.
    Barnes PJ; Fitzgerald GA; Dollery CT
    Clin Sci (Lond); 1982 Apr; 62(4):349-54. PubMed ID: 6279351
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating histamine and eosinophil cationic protein levels in nocturnal asthma.
    Fitzpatrick MF; Mackay T; Walters C; Tai PC; Church MK; Holgate ST; Douglas NJ
    Clin Sci (Lond); 1992 Aug; 83(2):227-32. PubMed ID: 1327639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stability of the circadian alteration in lung function in asthma.
    Martin RJ; Cicutto LC; Ackerson LM
    J Allergy Clin Immunol; 1992 Mar; 89(3):703-8. PubMed ID: 1545091
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variability of peak expiratory flow rate as a prognostic index in asymptomatic asthma.
    Bellia V; Cibella F; Coppola P; Greco V; Insalaco G; Milone F; Oddo S; Peralta G
    Respiration; 1984; 46(3):328-33. PubMed ID: 6494629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Can peak expiratory flow measurements estimate small airway function in asthmatic children?
    Goldberg S; Springer C; Avital A; Godfrey S; Bar-Yishay E
    Chest; 2001 Aug; 120(2):482-8. PubMed ID: 11502647
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adrenaline and nocturnal asthma.
    Morrison JF; Teale C; Pearson SB; Marshall P; Dwyer NM; Jones S; Dean HG
    BMJ; 1990 Sep; 301(6750):473-6. PubMed ID: 2207401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Underestimation of the peak flow variability in asthmatic children: evaluation of a new formula.
    Vargas MH; Ruiz-Gutiérrez HH; Espinosa-Serafin C; Zúñiga-Vázquez G; Furuya ME
    Pediatr Pulmonol; 2005 Apr; 39(4):325-31. PubMed ID: 15704185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Salmeterol HFA is as effective as salmeterol CFC in children and adults with persistent asthma.
    Chopra N; Williams M; Rimmer M; Kahl L; Jenkins M;
    Respir Med; 2005 Apr; 99 Suppl A():S1-S10. PubMed ID: 15777603
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nocturnal waking and morning dip of peak expiratory flow in clinically stable asthma patients during treatment. Occurrence and patient characteristics.
    Van Keimpema AR; Ariaansz M; Tamminga JJ; Nauta JJ; Postmus PE
    Respiration; 1997; 64(1):29-34. PubMed ID: 9044472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.